Immune Dysfunction and Infections in Patients With Cirrhosis (Q37852409)

24 August 2017

1 reference

title

Immune dysfunction and infections in patients with cirrhosis (English)

1 reference

24 August 2017

Immune Dysfunction and Infections in Patients With Cirrhosis (English)

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

27 November 2024

0 references

3

K Rajender Reddy

1 reference

24 August 2017

author name string

Chalermrat Bunchorntavakul

2

1 reference

24 August 2017

Alexander R. Bonnel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21397731

27 November 2024

language of work or name

English

0 references

publication date

11 March 2011

1 reference

full work available at URL

24 August 2017

https://api.elsevier.com/content/article/PII:S1542356511002370?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

https://api.elsevier.com/content/article/PII:S1542356511002370?httpAccept=text/plain

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Clinical Gastroenterology and Hepatology

27 November 2024

published in

1 reference

24 August 2017

volume

9

1 reference

24 August 2017

issue

9

1 reference

24 August 2017

page(s)

727-738

1 reference

Bacterial infections, sepsis, and multiorgan failure in cirrhosis

24 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis

27 November 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis

27 November 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.

27 November 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis.

27 November 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Gut microflora in the pathogenesis of the complications of cirrhosis

27 November 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Prevention and treatment of infections in patients with cirrhosis

27 November 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Liver bacterial clearance following hepatic artery ligation and portacaval shunt

27 November 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Patients with acute on chronic liver failure display "sepsis-like" immune paralysis

27 November 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease

27 November 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Bacterial infection-related morbidity and mortality in cirrhosis

27 November 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Impaired tuftsin activity in cirrhosis: relationship with splenic function and clinical outcome

27 November 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Deficient phospholipase C activity in blood polimorphonuclear neutrophils from patients with liver cirrhosis.

27 November 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Impaired superoxide anion, platelet-activating factor, and leukotriene B4 synthesis by neutrophils in cirrhosis

27 November 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Ammonia impairs neutrophil phagocytic function in liver disease

27 November 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

In Vitro Study of Neutrophil Apoptosis in Liver Cirrhosis

27 November 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils

27 November 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Opsonophagocytic dysfunction in patients with liver cirrhosis and low responses to tumor necrosis factor-alpha and lipopolysaccharide in patients' blood.

27 November 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis

27 November 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis

27 November 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

27 November 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Drinking pattern and socio-cultural aspects on immune response: an overview.

27 November 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: relationship with liver disease and ethanol intake

27 November 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Bacterial translocation (BT) in cirrhosis

27 November 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis

27 November 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Abnormalities in proximal small bowel motility in patients with cirrhosis

27 November 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis

27 November 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis

27 November 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Renal Failure in Patients With Cirrhosis and Sepsis Unrelated to Spontaneous Bacterial Peritonitis: Value of MELD Score

27 November 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features

27 November 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.

27 November 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Severe sepsis in cirrhosis.

27 November 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome.

27 November 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Prognostic Value of Plasma Endotoxin Levels in Patients with Cirrhosis

27 November 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients

27 November 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Coagulation disorders in patients with cirrhosis and severe sepsis

27 November 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Increased plasma malondialdehyde in patients with viral cirrhosis and its relationships to plasma nitric oxide, endotoxin, and portal pressure

27 November 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia

27 November 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock

27 November 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival.

27 November 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

The hepatoadrenal syndrome: a common yet unrecognized clinical condition

27 November 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

27 November 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Hydrocortisone therapy for patients with septic shock

27 November 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial.

27 November 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis

27 November 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Prognostic significance of bacterial infection in bleeding cirrhotic patients: A prospective study

27 November 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding

27 November 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Bacterial infection in the pathogenesis of variceal bleeding.

27 November 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

A prospective study of bacterial infections in patients with cirrhosis

27 November 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.

27 November 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Antibiotic prophylaxis using third generation cephalosporins can reduce the risk of early rebleeding in the first acute gastroesophageal variceal hemorrhage: a prospective randomized study

27 November 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial

27 November 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding

27 November 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

beta-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis.

27 November 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites

27 November 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Beta-blockers in cirrhosis: Friend and foe?

27 November 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites

27 November 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis

27 November 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study

27 November 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study

27 November 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club

27 November 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis

27 November 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Management of adult patients with ascites due to cirrhosis: an update

27 November 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Improved method for bacteriological diagnosis of spontaneous bacterial peritonitis

27 November 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Review article: the utility of reagent strips in the diagnosis of infected ascites in cirrhotic patients

27 November 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

A new highly sensitive point of care screen for spontaneous bacterial peritonitis using the leukocyte esterase method

27 November 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Characterisation of bacteria in ascites—reporting the potential of culture-independent, molecular analysis

27 November 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Identification of bacterial DNA in neutrocytic and non-neutrocytic cirrhotic ascites by means of a multiplex polymerase chain reaction.

27 November 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Secondary bacterial peritonitis in cirrhosis: a retrospective study of clinical and analytical characteristics, diagnosis and management.

27 November 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary from secondary bacterial peritonitis with intestinal perforation

27 November 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary

27 November 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis

27 November 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis

27 November 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis

27 November 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study

27 November 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Cefotaxime twice daily versus ceftriaxone once daily

27 November 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis.

27 November 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost

27 November 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis

27 November 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis

27 November 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality.

27 November 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study

27 November 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Pilot study: Gelafundin (polygeline) 4% plus antibiotics in the treatment of high-risk cirrhotic patients with spontaneous bacterial peritonitis

27 November 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime

27 November 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Long-term prognosis of cirrhosis after spontaneous bacterial peritonitis treated with ceftriaxone

27 November 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors

27 November 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

27 November 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short- and long-term administration, with daily and weekly dosages

27 November 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial

27 November 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Effect of long-term trimethoprim-sulfamethoxazole prophylaxis on ascites formation, bacterial translocation, spontaneous bacterial peritonitis, and survival in cirrhotic rats

27 November 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Role of fluoroquinolones in the primary prophylaxis of spontaneous bacterial peritonitis: meta-analysis

27 November 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis

27 November 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Prevalence and risk factors of bacteriuria in cirrhotic patients: a prospective case-control multicenter study in 244 patients

27 November 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Bacteriuria in patients with cirrhosis

27 November 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Prevalence and risk factors for bacteriuria in patients with cirrhosis

27 November 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Urinary tract infection in cirrhotic patients, a urodynamic explanation

27 November 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Pneumococcal pneumonia in a rat model of cirrhosis: effects of cirrhosis on pulmonary defense mechanisms against Streptococcus pneumoniae

27 November 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

27 November 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

A prediction rule for estimating the risk of bacteremia in patients with community-acquired pneumonia

27 November 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Bacterial infections in patients with cirrhosis

27 November 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Health maintenance issues in cirrhosis

27 November 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Risk factors for the outcome of cirrhotic patients with soft tissue infections

27 November 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Necrotizing fasciitis in patients with liver cirrhosis: predominance of monomicrobial Gram-negative bacillary infections

27 November 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Necrotising fasciitis: clinical features in patients with liver cirrhosis

27 November 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Infectious endocarditis in patients with cirrhosis of the liver: a model of infection in the frail patient.

27 November 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Nosocomial enterococcal endocarditis: a serious hazard for hospitalized patients with enterococcal bacteraemia

27 November 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Fibroblasts can be genetically modified to produce excitable cells capable of electrical coupling.

27 November 2024

114

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Open-heart surgery in patients with liver cirrhosis: indications, risk factors, and clinical outcomes

27 November 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Incidence and prognosis of tuberculosis in patients with cirrhosis of the liver. A Danish nationwide population based study

27 November 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Clinical characteristics of tuberculosis in patients with liver cirrhosis

27 November 2024

117

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Tuberculous peritonitis in cirrhotic patients: comparison of spontaneous bacterial peritonitis caused by Escherichia coli with tuberculous peritonitis

27 November 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Ascitic fluid adenosine deaminase insensitivity in detecting tuberculous peritonitis in the United States

27 November 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Tuberculous peritonitis: laparoscopic diagnosis of an uncommon disease in the United States

27 November 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective

27 November 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Editorial: Clostridium difficile infection: Yet another predictor of poor outcome in cirrhosis

27 November 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis.

27 November 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Cirrhotic Patients Are at Risk for Health Care–Associated Bacterial Infections

27 November 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection

27 November 2024

125

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia--a five-year retrospective review

27 November 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.

27 November 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Changes in the profiles of causative agents and antibiotic resistance rate for spontaneous bacterial peritonitis: an analysis of cultured microorganisms in recent 12 years

27 November 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Cryptococcus neoformans peritonitis in a patient with alcoholic cirrhosis: case report and review of the literature

27 November 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Cryptococcaemia: clinical features and prognostic factors

27 November 2024

131

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Spontaneous cryptococcal peritonitis in patients with liver cirrhosis.

27 November 2024

132

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Cryptococcal Peritonitis Complicating Hepatic Failure: Case Report and Review of the Literature

27 November 2024

133

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Prevalence, associations, and trends of biliary-tract candidiasis: a prospective observational study

27 November 2024

134

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Biliary candida infections in primary sclerosing cholangitis

27 November 2024

135

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Association of hemochromatosis with infectious diseases: expanding spectrum

27 November 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Hepcidin: the missing link between hemochromatosis and infections

27 November 2024

137

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Vibrio vulnificus hazard in patients with liver disease

27 November 2024

138

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Infectious complications of cirrhosis

27 November 2024

139

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Multiple liver abscesses due to Yersinia enterocolitica discloses primary hemochromatosis: three cases reports and review.

27 November 2024

140

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Liver abscesses due to Yersinia enterocolitica in patients with haemochromatosis

27 November 2024

141

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Biliary tract infection and bacteraemia: presentation, structural abnormalities, causative organisms and clinical outcomes.

27 November 2024

143

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Review article: antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP).

27 November 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers.

27 November 2024

145

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis

27 November 2024

146

1 reference

https://api.crossref.org/works/10.1016/J.CGH.2011.02.031

27 November 2024

Identifiers

1 reference

24 August 2017

1 reference